Therefore, NKILA could exert a context-dependent role as a regulator of NFκB signaling and metastasis, suggesting the potential of this lncRNA as a therapeutic target to modulate the function of tumor-specific T cells in BC. This evidence concerns the gene NFKB1 and breast cancer.